Document 0573
 DOCN  M9550573
 TI    Genetic approaches designed to minimize cytotoxicity of retroviral
       protease.
 DT    9505
 AU    Rizzo CJ; Korant BD; Virus Laboratory, DuPont Merck Company, Glenolden,
       Pennsylvania; 19036.
 SO    Methods Enzymol. 1994;241:16-29. Unique Identifier : AIDSLINE
       MED/95157309
 DE    beta-Lactamases/GENETICS/*METABOLISM  Amino Acid Sequence
       Bacillus/GENETICS  Biological Transport  Cloning, Molecular/*METHODS
       *Cytopathogenic Effect, Viral  Escherichia coli  Gene Expression
       Regulation, Bacterial  Gene Expression Regulation, Enzymologic  Genes,
       Synthetic  Genetic Vectors  HIV Protease/GENETICS/*METABOLISM
       HIV-1/*ENZYMOLOGY/GENETICS/PHYSIOLOGY  Molecular Sequence Data  Promoter
       Regions (Genetics)  Protein Processing, Post-Translational  Recombinant
       Fusion Proteins/*METABOLISM  Solubility  T-Phages/GENETICS  JOURNAL
       ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).